Glycans in melanoma screening. Part 2. Towards the understanding of integrin N-glycosylation in melanoma

Biochemical Society Transactions

Volumn 39, Issue 1, 2011, Pages 374-377

  Link Lenczowski, Paweł ^a   Lityńska, Anna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Glycan; Integrin; Melanoma screening; N glycosylation

Indexed keywords

GLYCAN DERIVATIVE; INTEGRIN;

BIOMEDICINE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SCREENING; CONFERENCE PAPER; FUCOSYLATION; GLYCOBIOLOGY; HUMAN; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN GLYCOSYLATION; SIALYLATION;

DISEASE PROGRESSION; EARLY DETECTION OF CANCER; GLYCOSYLATION; HUMANS; INTEGRINS; MELANOMA; POLYSACCHARIDES; SKIN NEOPLASMS;

EID: 79551504131     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390374     Document Type: Conference Paper

References (42)

1. Linette, G.P., Carlson, J.A., Slominski, A., Mihm, M.C. and Ross, J.S. (2005) Biomarkers in melanoma: stage III and IV disease. Expert Rev. Mol. Diagn. 5, 65-74
2. Balch, C.M., Soong, S.J., Atkins, M.B., Buzaid, A.C., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton, Jr, A., Kirkwood, J.M. et al. (2004) An evidence-based staging system for cutaneous melanoma. CA Cancer J. Clin. 54, 131-149
3. Meier, F., Satyamoorthy, K., Nesbit, M., Hsu, M.Y., Schittek, B., Garbe, C. and Herlyn, M. (1998) Molecular events in melanoma development and progression. Front. Biosci. 3, D1005-D1010
4. Herlyn, M. and Fukanaga-Kalabis, M. (2010) What is a good model for melanoma? J. Invest. Dermatol. 130, 911-912
5. Janik, M.E., Lityńska, A. and Vereecken, P. (2010) Cell migration-the role of integrin glycosylation. Biochim. Biophys. Acta 1800, 545-555
6. Ohtsubo, K. and Marth, J.D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867
7. Turnbull, J.E. and Field, R.A. (2007) Emerging glycomics technologies. Nat. Chem. Biol. 3, 74-77
8. Dennis, J.W., Granovsky, M. and Warren, C.E. (1999) Protein glycosylation in development and disease. BioEssays 21, 412-421
9. Royle, L., Campbell, M.P., Radcliffe, C.M., White, D.M., Harvey, D.J., Abrahams, J.L., Kim, Y.G., Henry, G.W., Shadick, N.A., Weinblatt, M.E. et al. (2008) HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 376, 1-12
10. North, S.J., Hitchen, P.G., Haslam, S.M. and Dell, A. (2009) Mass spectrometry in the analysis of N-linked and O-linked glycans. Curr. Opin. Struct. Biol. 19, 498-506
11. Laughlin, S.T. and Bertozzi, C.R. (2009) Imaging the glycome. Proc. Natl. Acad. Sci. U.S.A. 106, 12-17
12. Dube, D.H. and Bertozzi, C.R. (2005) Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discovery 4, 477-488
13. Drake, P.M., Cho, W., Li, B., Prakobphol, A., Johansen, E., Anderson, N.L., Regnier, F.E., Gibson, B.W. and Fisher, S.J. (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 56, 223-236
14. An, H.J., Kronewitter, S.R., de Leoz, M.L. and Lebrilla, C.B. (2009) Glycomics and disease markers. Curr. Opin. Chem. Biol. 13, 601-607
15. Fuster, M.M. and Esko, J.D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526-542
16. Brooks, S.A., Carter, T.M., Royle, L., Harvey, D.J., Fry, S.A., Kinch, C., Dwek, R.A. and Rudd, P.M. (2008) Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Anticancer Agents Med. Chem. 8, 2-21
17. Litynska, A., Przybylo, M., Hoja-Lukowicz, D., Pochec, E., Kremser, M., Ciolczyl-Wierzbicka, D., Łabȩdź, M. and Laidler, P. (2008) Protein glycosylation as marker of melanoma progression. Curr. Cancer Ther. Rev. 4, 144-148
18. Hakamori, S. (2001) Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv. Exp. Med. Biol. 491, 369-402
19. Wang, P.H. (2005) Altered glycosylation in cancer: sialic acids and sialyltransferases. J. Cancer Molecules 1, 73-81
20. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U.S.A. 99, 10231-10233
21. Laidler, P., Lityńska, A., Hoja-Łukowicz, D., Łabedz, M., Przybyło, M., Ciołczyk-Wierzbicka, D., Pocheć, E., Trebacz, E. and Kremser, E. (2006) Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immunol. Immunother. 55, 112-118
22. Haass, N.K., Smalley, K.S., Li, L. and Herlyn, M. (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 3, 150-159
23. Li, G., Satyamoorthy, K. and Herlyn, M. (2002) Dynamics of cell interactions and communications during melanoma development. Crit. Rev. Oral Biol. Med. 13, 62-70
24. Kalluri, R. and Weinberg, R.A. (2009) The basics of epithelial- mesenchymal transition. J. Clin. Invest. 119, 1420-1428
25. Li, G., Satyamoorthy, K. and Herlyn, M. (2001) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 61, 3819-3825
26. Ciołczyk-Wierzbicka, D., Amoresano, A., Casbarra, A., Hoja-Łukowicz, D., Lityńska, A. and Laidler, P. (2004) The structure of the oligosaccharides of N-cadherin from human melanoma cell lines. Glycoconj. J. 20, 483-492
27. Hynes, R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687
28. Schwartz, M.A., Schaller, M.D. and Ginsberg, M.H. (1995) Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599
29. Johnson, J.P. (1999) Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 18, 345-357
30. Mizejewski, G.J (1999) Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exp. Biol. Med. 222, 124-138
31. Sauter, E.R. and Herlyn, M. (1998) Molecular biology of human melanoma development and progression. Mol. Carcinog. 23, 132-143
32. Voura, E.B., Ramjeesingh, R.A., Montgomery, A.M. and Siu, C.H. (2001) Involvement of integrin αvβ3 and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol. Biol. Cell 12, 2699-2710
33. Dwek, R.A. (1996) Glycobiology: toward understanding the function of sugars. Chem. Rev. 96, 683-720
34. Ono, M. and Hakomori, S. (2004) Glycosylation defining cancer cell motility and invasiveness. Glycoconj. J. 20, 71-78
35. Gu, J. and Taniguchi, N. (2004) Regulation of integrin functions by N-glycans. Glycoconj. J. 21, 9-15
36. Zhao, Y., Sato, Y., Isaji, T., Fukuda, T., Matsumoto, A., Miyoshi, E., Gu, J. and Taniguchi, N. (2008) Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275, 1939-1948
37. Isaji, T., Sato, Y., Zhao, Y., Miyoshi, E., Wada, Y., Taniguchi, N. and Gu, J. (2006) N-glycosylation of the β-propeller domain of the integrin α5 subunit is essential for α5β1 heterodimerization, expression on the cell surface, and its biological function. J. Biol. Chem. 281, 33258-33267
38. Gu, J., Isaji, T., Sato, Y., Kariya, Y. and Fukuda, T. (2009) Importance of N-glycosylation on α5β1 integrin for its biological functions. Biol. Pharm. Bull. 32, 780-785
39. Luo, B.H., Springer, T.A. and Takagi, J. (2003) Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc. Natl. Acad. Sci. U.S.A. 100, 2403-2408
40. Liu, Y., Pan, D., Bellis, S.L. and Song, Y. (2008) Effect of altered glycosylation on the structure of the I-like domain of β1 integrin: a molecular dynamics study. Proteins 73, 989-1000
41. Pocheć, E., Lityńska, A., Amoresano, A. and Casbarra, A. (2003) Glycosylation profile of integrin α3β1 changes with melanoma progression. Biochim. Biophys. Acta 1643, 113-123
42. Kremser, M.E., Przybyło, M., Hoja-Łukowicz, D., Pocheć, E., Amoresano, A., Carpentieri, A., Bubka, M. and Lityńska, A. (2008) Characterisation of α3β1 and αvβ3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines. Biochim. Biophys. Acta 1780, 1421-1431